What is Databiology?
Headquartered in Oxford and San Francisco, Databiology operates as a specialized software and services provider dedicated to the complex requirements of the life sciences sector. The company provides a robust enterprise platform designed to manage the lifecycle of omics data, facilitating interoperability across scientific, commercial, and clinical applications. By addressing the critical bottleneck of data management in R&D, Databiology enables its clients to optimize their information assets, ensuring that large-scale datasets are not only stored but effectively utilized for sustainable scientific discovery. Its market position is defined by its ability to deliver scalable, best-in-class solutions that meet the rigorous demands of global pharmaceutical and biotech enterprises.
How much funding has Databiology raised?
Databiology has raised a total of $33K across 1 funding round:
Debt
$33K
Debt (2021): $33K with participation from PPP
Key Investors in Databiology
PPP
Public-Private Partnership
What's next for Databiology?
With this recent infusion of capital, Databiology is well-positioned to accelerate its strategic roadmap, focusing on the expansion of its enterprise platform capabilities. The company is expected to prioritize the integration of advanced analytics and enhanced interoperability features to support the increasing complexity of omics research. As the industry shifts toward more data-intensive workflows, Databiology's focus on sustainable information management will likely serve as a key differentiator. Future growth initiatives will likely involve deepening its footprint in key global markets and refining its service offerings to support the next generation of economically effective scientific breakthroughs, ultimately reinforcing its status as a critical infrastructure partner for the global life sciences community.
See full Databiology company page
